IL22 and Hepatic fibrosis: On the one hand, IL-22 attenuates liver fibrosis by activating the Nrf2-ARE pathway, reducing the level of oxidative stress and inhibiting the activation and proliferation of hepatic stellate cells (HSC) (33).